Inhibitor incidence in haemophilia A under exclusive use of a third-generation recombinant factor VIII concentrate: results of the HEMFIL Cohort Study

Letícia L. Jardim, Johanna van der Bom, Christina C. Brommonschenkel, Samantha C. Gouw, Suely M. Rezende, on the behalf of the HEMFIL Study Group

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Pages (from-to)152-155
Number of pages4
JournalBritish Journal of Haematology
Volume186
Issue number1
DOIs
Publication statusPublished - 1 Jul 2019
Externally publishedYes

Cite this

Jardim, L. L., van der Bom, J., Brommonschenkel, C. C., Gouw, S. C., Rezende, S. M., & on the behalf of the HEMFIL Study Group (2019). Inhibitor incidence in haemophilia A under exclusive use of a third-generation recombinant factor VIII concentrate: results of the HEMFIL Cohort Study. British Journal of Haematology, 186(1), 152-155. https://doi.org/10.1111/bjh.15728